STONY BROOK, NY -- (Marketwired) -- 05/24/16

 Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA), a provider of DNA-based supply chain, anti-counterfeiting and anti-theft technology, product genotyping and product authentication solutions, announced that management is scheduled to participate at the Mauldin Economics Strategic Investment Conference in Dallas, Texas, May 24 through May 27, 2016. The theme of this conference is 'Decade of Disruption: Investing in a Transformed World' and it is expected that over 700 investors will be in attendance.

One of only three companies invited to participate at the conference, Applied DNA's President and Chief Executive Officer, Dr. James Hayward, will participate in a panel discussion on the most important breakthroughs in biotechnology on Wednesday, May 25 and Thursday, May 26. Applied DNA will also be an exhibitor at this conference which attracts high net worth individuals and financial professionals from around the world.

"Residing at the intersection of technology, market opportunity and the ability to transform our daily lives, the Strategic Investment Conference enables us to expand the awareness of Applied DNA with investors who invest in tomorrow's disruptive technologies today," stated Dr. Hayward. "Applied DNA's contribution has been to redefine "TRUST" using the biology of authenticity. The global societal and economic future relies on clear definitions of identity ("Trust me, this drug is the real thing"), origin ("Trust me, this is Italian"), claims ("Trust me, this was organically grown"), composition ("Trust me, this is 100% Pima cotton"), and ethical sourcing ("Trust me, no child labor helped to produce this product"). The Applied DNA solution is already being deployed in textiles and apparel through DNA marking of 100 million pounds of cotton. Over 500,000 critical microchips have been DNA marked, protecting our war fighters around the world. We also are securing ATMs in Europe and protecting over 1 million personal assets globally.Our convergence of biotech and information technologies enable DNA-based security solutions to answer the formidable macroeconomic and geopolitical challenges of our day and of tomorrow. Judy Murrah, our Chief Information Officer, and I look forward to presenting Applied DNA to the attendees of this prestigious conference." 

If you would like to schedule a one-on-one meeting with the Company's management team at the conference, please email Debbie Bailey, Investor Relations Officer, on Debbie.bailey@adnas. For more information about the Mauldin Economics Strategic Investment Conference, please visit mauldineconomics.com/sic-2016. 

About Applied DNA Sciences
We make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. Our patented DNA-based solutions can be used to identify, tag, track, and trace products, to help assure authenticity, traceability and quality of products. SigNature® DNA describes the platform ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward textiles and apparel, DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. We are also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.

Go to adnas.comfor more information, events and to learn more about how Applied DNA Sciences makes life real and safe. Common stock listed on NASDAQ under the symbol APDN, and warrants are listed under the symbol APDNW. 

Forward-Looking Statements
The statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 14, 2015,and our subsequent quarterly reports on Form 10-Q filed on February 10, 2016 and May 12, 2016 which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Investor contact:
Debbie Bailey
631-240-8817 
debbie.bailey@adnas.com

Media contact:
Susan Forman
Dian Griesel Int'l.
212-825-3210
sforman@dgicomm.com

web: www.adnas.com
twitter: @APDN